Poon Stephanie, Leis Benjamin, Lambert Laurie, MacFarlane Kendra, Anderson Kim, Blais Claudia, Demers Catherine, Ezekowitz Justin A, Hawkins Nathaniel M, Lee Douglas S, Moe Gordon, Sandhu Roopinder K, Virani Sean A, Wilton Stephen, Zieroth Shelley, McKelvie Robert
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
CJC Open. 2022 Aug 12;4(8):667-675. doi: 10.1016/j.cjco.2022.04.011. eCollection 2022 Aug.
An unanswered question is whether the combination of advances in medical and device therapy over the past decade has translated into improved outcomes for patients with heart failure (HF) in Canada.
The Canadian Institute for Health Information (CIHI) Hospital Morbidity Database was used to identify hospitalizations for HF among patients aged 18 years and older in Canadian hospitals during fiscal years 2009/2010 and 2018/2019. We assessed interprovincial differences in age, sex, length of stay (LOS), discharge disposition, type of admitting hospital, and most responsible service, for all HF admissions. National and provincial rates of HF admissions and all-cause 30-day readmissions were calculated.
After adjusting for age, the rate of HF admissions in Canada was 216 per 100,000 population in 2009/2010 and 2018/2019. The majority of patients with HF were admitted to general internal medicine and community hospitals in both 2009/2010 and 2018/2019. The national, crude, all-cause 30-day readmission rate stayed constant at 20.6%, and the majority of patients were readmitted with the diagnosis of HF in both 2009/2010 (62.5%) and 2018/2019 (59.0%). Median and interquartile range of HF LOS also remained unchanged at 7 days (3-14).
The national rate of HF admissions, 30-day readmissions, and HF LOS have remained unchanged from 2009/2010 to 2018/2019, despite advances in medical and device therapy during this timeframe.
过去十年间，医学和器械治疗取得了诸多进展，这些进展是否已转化为加拿大心力衰竭（HF）患者更好的治疗效果，这一问题仍未得到解答。
利用加拿大卫生信息研究所（CIHI）的医院发病率数据库，确定2009/2010财年和2018/2019财年期间加拿大医院18岁及以上HF患者的住院情况。我们评估了所有HF入院患者在年龄、性别、住院时间（LOS）、出院处置、收治医院类型和主要负责科室方面的省际差异。计算了全国和各省的HF入院率以及全因30天再入院率。
调整年龄后，2009/2010年和2018/2019年加拿大的HF入院率均为每10万人216例。2009/2010年和2018/2019年，大多数HF患者入住普通内科和社区医院。全国粗全因30天再入院率保持在20.6%不变，2009/2010年（62.5%）和2018/2019年（59.0%），大多数患者再次入院时的诊断为HF。HF住院时间的中位数和四分位间距也保持在7天（3 - 14天）不变。
尽管在此期间医学和器械治疗有所进展，但从2009/2010年到2018/2019年，加拿大的HF入院率、30天再入院率和HF住院时间均未发生变化。
